Understanding the Benefit of Combining GLP-1 Agonists With Exercise: Time Will Tell.
J Clin Endocrinol Metab · 2024
Last updated 2026-09-22| Journal | J Clin Endocrinol Metab, 2024 |
|---|---|
| Citations | 3 |
| Relative citation ratio | 0.51 |
| NIH percentile | 29 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction |
Full record and abstract on PubMed 37493062 ↗